US Broker Ratings

NICE Ltd (NICE) Stock Analysis: Exploring a 42% Upside Potential in the Tech Sector

NICE Ltd (NASDAQ: NICE), a key player in the technology sector, is capturing investor attention with its robust capabilities in AI-powered cloud platforms tailored for customer engagement and financial crime..

Mitek Systems, Inc. (MITK) Stock Analysis: Unveiling a 25.59% Potential Upside for Tech Investors

For investors seeking opportunities in the technology sector, Mitek Systems, Inc. (NASDAQ: MITK) presents an intriguing prospect. With a current market capitalization of $482.58 million, Mitek is a key player..

Absci Corporation (ABSI) Investor Outlook: Unpacking a 136% Potential Upside in Biotech Innovation

For investors with a keen eye on the biotechnology sector, Absci Corporation (NASDAQ: ABSI) presents a compelling opportunity. With a market capitalization of $524.8 million, this healthcare company has carved..

Benitec Biopharma Inc. (BNTC) Stock Analysis: A Biotechnology Gem with 85.60% Upside Potential

Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology firm, is capturing the attention of growth-focused investors with its innovative approach to genetic medicine and a striking potential upside of 85.60%...

Upbound Group, Inc. (UPBD) Stock Analysis: Exploring a 78.67% Potential Upside

For individual investors with an eye on the technology sector, Upbound Group, Inc. (NYSE: UPBD) presents a compelling case. The company, which operates primarily in the software application industry, has..

Intapp, Inc. (INTA) Stock Analysis: Exploring a 25% Upside Potential Amidst Robust Revenue Growth

Intapp, Inc. (NASDAQ: INTA), a technology company operating within the Software – Application industry, has captured investor attention with its AI-powered solutions for professional and financial services firms. Despite recent..

ALT5 Sigma Corporation (ALTS) Stock Analysis: Navigating Growth in Blockchain and Biotech

ALT5 Sigma Corporation, trading under the symbol ALTS, presents a compelling narrative for investors intrigued by the intersection of blockchain technology and biotechnology. Based in Las Vegas, Nevada, ALT5 Sigma,..

Docebo Inc. (DCBO) Stock Analysis: Uncovering a Potential 62.57% Upside in the Learning Management Sector

Docebo Inc. (NASDAQ: DCBO), a prominent player in the technology sector, specializes in providing a sophisticated learning management platform. As of now, the company stands at a market capitalization of..

Alight, Inc. (ALIT) Stock Analysis: A Deep Dive into Its 185% Potential Upside

For investors looking to explore opportunities within the technology sector, Alight, Inc. (NYSE: ALIT) presents a compelling case with its notable 185.71% potential upside. This Chicago-based company operates in the..

InterDigital, Inc. (IDCC)

⚠️ No article content returned.

..

SmartRent, Inc. (SMRT) Stock Analysis: Navigating the Challenges with Growth Potential in Real Estate Tech

SmartRent, Inc. (SMRT), a key player in the burgeoning technology sector, particularly within the software application industry, is poised at an intriguing crossroads for investors. With a market capitalization of..

Asure Software Inc (ASUR) Stock Analysis: Exploring a 40% Potential Upside Amid Strong Buy Ratings

Asure Software Inc (ASUR), a prominent player in the Technology sector, particularly within the Software – Application industry, presents a compelling investment narrative for those eyeing growth opportunities. Based in..

Sapiens International (SPNS) Stock Analysis: Navigating Growth with a 12.95% ROE and Steady Dividends

Sapiens International Corporation (NASDAQ: SPNS), a prominent player in the software application industry, is making waves in the technology sector. Headquartered in Holon, Israel, Sapiens specializes in providing cutting-edge software..

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: A 66% Potential Upside Beckons Investors

CytomX Therapeutics, Inc. (NASDAQ: CTMX) has emerged as a compelling entity in the biotechnology sector, offering intriguing prospects for investors seeking exposure to oncology-focused innovation. With a market capitalization of..

Heron Therapeutics, Inc. (HRTX) Investor Outlook: Exploring a 246% Potential Upside

Heron Therapeutics, Inc. (NASDAQ: HRTX), a biotechnology company specializing in innovative drug delivery systems, is gaining investor attention due to its remarkable potential upside of 246.15%. Despite facing some financial..

Tvardi Therapeutics, Inc. (TVRD) Stock Analysis: Exploring a 101.55% Potential Upside in Biotech

Tvardi Therapeutics, Inc. (TVRD), a clinical-stage biopharmaceutical company based in Sugar Land, Texas, is making waves in the biotechnology sector with its innovative approach to treating fibrosis-driven diseases. With a..

ServiceTitan, Inc. (TTAN): Investor Outlook Reveals 27.64% Potential Upside Amid Robust Revenue Growth

ServiceTitan, Inc. (NASDAQ: TTAN), a leader in cloud-based software solutions for the service industry, is drawing attention from the investor community due to its promising growth trajectory and substantial market..

Palvella Therapeutics, Inc. (PVLA) Stock Analysis: Unpacking a Promising 74% Upside Potential

Palvella Therapeutics, Inc. (NASDAQ: PVLA) is making waves in the biotechnology sector with its focus on transforming the treatment landscape for serious and rare genetic skin diseases. Based in Wayne,..

Applovin Corporation (APP) Stock Analysis: Navigating a $227.92 Billion Market Cap with Strong Revenue Growth

For investors eyeing opportunities in the Communication Services sector, Applovin Corporation (APP) emerges as a compelling candidate. With a market capitalization of $227.92 billion, Applovin is a formidable player in..

Digital Turbine, Inc. (APPS) Stock Analysis: Exploring a 75% Upside Potential Amidst Strategic Growth

In the ever-evolving landscape of the technology sector, Digital Turbine, Inc. (NASDAQ: APPS) stands out with its innovative mobile growth platform that caters to advertisers, publishers, carriers, and device OEMs...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds